COVID-19 vaccines for people who are moderately or severely immunocompromised

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

COVID-19 vaccines for people who are moderately or severely immunocompromised

Sept. 2, 2022
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

[PDF-566.84 KB]

Details Supporting Files You May Also Like

Details:

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

Updated Sept. 2, 2022
Content Notes:

Pre-teens, Teens and Adults Who Are Moderately or Severely Immunocompromised -- Children Ages 6 Months-11 Years Who Are Moderately or Severely Immunocompromised -- Who Is Moderately or Severely Immunocompromised? -- People Who Were Vaccinated Outside of the United States -- Frequently Asked Questions.
Subjects:

[+]

COVID-19 COVID-19 Vaccines Immunization, Secondary Immunocompromised Host Vaccination
Document Type:

Webpage
Name as Subject:

Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine ; Novavax vaccine ; Pfizer-BioNTech COVID-19 vaccine

Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine ; Novavax vaccine ; Pfizer-BioNTech COVID-19 vaccine Less -
Place as Subject:

United States
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:752f71364247f870874707c476d0e19a4371dd793a72bb959652263cdf5de833
Download URL:

https://stacks.cdc.gov/view/cdc/120868/cdc_120868_DS1.pdf
File Type:

immuno.html

htm

More +